Koleva-Kolarova, Rositsa http://orcid.org/0000-0002-8924-4671
Buchanan, James
Vellekoop, Heleen
Huygens, Simone
Versteegh, Matthijs
Mölken, Maureen Rutten-van
Szilberhorn, László
Zelei, Tamás
Nagy, Balázs
Wordsworth, Sarah
Tsiachristas, Apostolos
,
Funding for this research was provided by:
Horizon 2020 Framework Programme (824997)
Article History
Accepted: 28 December 2021
First Online: 4 April 2022
Declarations
:
: The HEcoPerMed project has received funding from the European Union’s Horizon 2020 research and innovation programme under Grant Agreement no. 824997.
: Sarah Wordsworth and James Buchanan are co-applicants of a project funded through Genome British Columbia’s GeneSolve programme and Illumina and have received travel support from Illumina to attend conferences in Baltimore (USA), Barcelona (Spain), and Basel (Switzerland). Heleen Vellekoop, Simone Huygens, Matthijs Versteegh, Maureen Rutten-van Mölken, László Szilberhorn, Tamás Zelei, Balázs Nagy, Rositsa Koleva-Kolarova, and Apostolos Tsiachristas have no conflicts of interest that are directly relevant to the content of this article.
: This study did not require approval by a medical ethics committee.
: Not applicable.
: Not applicable.
: Search strategies used for the systematic literature review and the selection criteria are available in the supplementary files. The Excel file used for the data extraction during the systematic literature review can be made available upon request.
: No programming was used in this study.
: AT and SW outlined the concept and broad methods for this study. AT, JB and RKK conducted the literature review and together with SW wrote the manuscript. All authors provided multiple rounds of critical feedback.